Publication | Closed Access
Open-Label Pilot Study of Vemurafenib in Previously Treated Metastatic Melanoma (MM) Patients (PTS) with Symptomatic Brain Metastases (BM)
14
Citations
0
References
2012
Year
Open-label Pilot StudyMedicineMelanomaPathologySymptomatic Brain MetastasesCancer TreatmentOncologyRadiation OncologyMolecular Oncology
No additional data available for this publication yet. Check back later!